Home -> Law Blog Directory -> Patent Law Blogs -> Patently Obvious
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patently ObviousAssistant Examiners and Patent Term Adjustment
By Dennis Crouch, Esq.
Newly minted patent examiners play the role of "assistant examiners" at the US patent office. The work of assistant examiners is reviewed by primary examiners, and both are reviewed by supervisory patent examiners as well as quality control specialists.
Of the roughly 160,000 utility patents issued in the past year (June 29,2008 ? June 29, 2009), about 37% were examined by an assistant examiner with the remaining 63% handled by primary examiners working alone. This proportion varies according to Technology Center.
Technology Center | Patents Issued | Percent Handled by | |
1600 | Biotechnology and Organic Chemistry | 11,667 | 38% |
1700 | Chemical and Materials Engineering | 16,857 | 28% |
2100 | Computer Architecture, Software, and Information Security | 16,217 | 47% |
2400 | Networking, Mulitplexing, Cable, and Security | 3,370 | 55% |
2600 | Communications | 23,758 | 42% |
2800 | Semiconductors, Electrical and Optical Systems and Components | 50,812 | 36% |
3600 | Transportation, Construction, Electronic Commerce, Agriculture, | 18,098 | 34% |
3700 | Mechanical Engineering, Manufacturing, Products | 18,018 | 30% |
4100 | Training Academy | 372 | 98% |
For applicants who appreciate delay, patents that were handled by assistant examiners are more likely to be eligible for patent term adjustment due to patent office delay. (This results hold true for each technology center). 80% of patents handled by assistant examiners were awarded some PTA while only 72% of those handled solely by a primary examiner. This translates to an expected PTA of 12 months versus 9 months respectively.
Only applications filed after May 29, 2000 are eligible for a patent term adjustment. Less than 99.5% of patents issued thus far in 2009 have a qualifying filing date. Over the past four years, the percent of patents with some patent term adjustment has been steadily rising over time.
Notes:
"The patent term adjustment (PTA) provisions of the American Inventors Protection Act of 1999 (AIPA) allow for term adjustment: (1) if the USPTO fails to initially act on an application within fourteen months of its filing date; (2) if the USPTO fails to respond to a reply or appeal by applicant within four months of the reply or appeal; (3) if the USPTO fails to act on an application within four months of a Board of Patent Appeals and Interferences (BPAI) or court decision in an application containing allowable claims; (4) if the USPTO fails to issue a patent within four months of the date the issue fee was paid; (5) if the USPTO fails to issue a patent within three years of its filing date; (6) if issue of a patent was delayed due to imposition of a secrecy order; (7) if issue of a patent was delayed due to an interference proceeding; or (8) if the issue of a patent was delayed due to successful appellate review. This PTA smorgasbord requires the USPTO and applicants to monitor numerous events during the prosecution of the application to determine the appropriate term adjustment, and often results in applicants obtaining patent term adjustment despite the fact that the patent has an unadjusted term of longer than seventeen years from grant.
The purpose of the patent term adjustment provision in the AIPA was to guarantee that diligent applicants would still have a patent term of at least seventeen years from grant under the twenty-year patent term system. If the USPTO issues the application within three years from its filing date, any patent term adjustment operates to overcompensate the patentee. PTA should be limited to the situations in which the USPTO delayed processing or examination of the patent and this delay resulted in the application pending before the USPTO for more than three years." Via USPTO
Full post as published by Patently Obvious on July 01, 2009 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
Rite Aid Corp. and Eckerd Corp.
allegedly failed to pay overtime to assistant store managers.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Pesticides
Long-Term Exposure Linked to Diabetes
Long-Term Insurance Suit
Settled for $15 Million

83% Chance of Patent Term Extension Due to USPTO Delay
She Lit a Candle and Showed Me the Way
New Website Creates Place to Examine the Examiners
So, How (and When) Will You Get Your Patent Term Adjustment Corrected









